Evidence map›Paper›PMID 41042002›Full record

ArticleRNA biology2025

Altering rRNA 2'O-methylation pattern during neuronal differentiation is regulated by FMRP.

Michelle Ninochka D'Souza, Naveen Kumar Chandappa Gowda, Nivedita Hariharan, Syed Wasifa Qadri, Dasaradhi Palakodeti, Ravi S Muddashetty

Abstract read
In one paragraph

Article in RNA biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michelle Ninochka D'SouzaCentre for Brain Research, Indian Institute of Science, Bangalore, India.
Naveen Kumar Chandappa GowdaCentre for Brain Research, Indian Institute of Science, Bangalore, India.
Nivedita HariharanDepartment of Chemical Biology Approaches for Stem Cells and Therapeutics (ICB), Institute for Stem Cell Science and Regenerative Medicine, GKVK Campus, Bangalore, India.
Syed Wasifa QadriCentre for Brain Research, Indian Institute of Science, Bangalore, India.
Dasaradhi PalakodetiDepartment of Chemical Biology Approaches for Stem Cells and Therapeutics (ICB), Institute for Stem Cell Science and Regenerative Medicine, GKVK Campus, Bangalore, India.
Ravi S MuddashettyCentre for Brain Research, Indian Institute of Science, Bangalore, India.ORCID 0000-0002-1373-6194

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Fragile X Messenger Ribonucleoprotein (FMRP) is a selective RNA-binding protein that localizes to the cytoplasm and the nucleus. The loss of FMRP results in Fragile X Syndrome (FXS), an autism spectrum disorder. FMRP interacts with ribosomes and regulates the translation of mRNAs essential for neuronal development and synaptic plasticity. However, the biochemical nature of this translation regulation is unknown. Here, we report that a potential feature of FMRP-mediated translation regulation during neuronal differentiation is the modulation of 2'-O-methylation of ribosomal RNA. 2'O-methylation, facilitated by C/D box snoRNAs in the nucleus, is a major epitranscriptome mark on rRNA, essential for ribosome assembly and function. We found that FMRP influences a distinct rRNA 2'O-Methylation pattern across neuronal differentiation. We show that in H9 ESCs, FMRP interacts with a selected set of C/D box snoRNA in the nucleus, resulting in the generation of ribosomes with a distinct pattern of rRNA 2'O-Methylation. This epitranscriptome pattern on rRNA undergoes a significant change during the differentiation of ESCs to neuronal precursors and cortical neurons. ESCs exhibit substantial levels of hypomethylated residues on rRNA, which progressively decrease in neuronal precursors and post-mitotic cortical neurons. This reduction correlates with changes in global protein synthesis across different stages of differentiation. Importantly, this stepwise change in the 2'O-methylation pattern during neuronal differentiation is altered in the absence of FMRP, which could impact neuronal development and contribute to dysregulated protein synthesis observed in Fragile X Syndrome.

Indexed as

Cell DifferentiationFragile X Messenger Ribonucleoprotein 1NeuronsRNA, RibosomalAnimalsCell LineEmbryonic Stem CellsFragile X SyndromeHumansMethylationMiceRibosomesRNA, Small NucleolarFragile X Messenger Ribonucleoprotein 1RNA, RibosomalRNA, Small NucleolarepitranscriptomeFMRPRibosomal RNAribosomesnoRNA

Identifiers

PMID41042002
PMCPMC12498540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.